The Sherwin-Williams Company
SHW
$318.00
-2.36%
The Sherwin-Williams Company is a leading global manufacturer and retailer of paints, coatings, and related products, operating in the Specialty Chemicals industry. It is defined by its dominant position as the largest provider of architectural paint in the United States, leveraging a vast network of company-owned stores and a premium brand strategy.…
SHW
The Sherwin-Williams Company
$318.00
Related headlines
Investment Opinion: Should I buy SHW Today?
Synthesized Analyst Rating: HOLD. The analysis reveals a company with exceptional operational strengths and brand power, currently facing cyclical headwinds and trading at a valuation that does not appear compellingly cheap. While the unanimous positive analyst sentiment and strong cash flows provide a floor, the high debt load, margin pressure, and technical downtrend suggest limited near-term upside potential. Investors should await clearer signs of margin stabilization or a more attractive entry point before establishing new positions.
Sign up to view all
SHW 12-Month Price Forecast
The outlook is balanced between strong underlying business quality and significant macro/financial risks. The base case of range-bound trading is most probable, with the bear case risk elevated due to leverage and the bull case dependent on a swift cyclical recovery.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Sherwin-Williams Company's 12-month outlook, with a consensus price target around $413.40 and implied upside of +30.0% versus the current price.
Average Target
$413.40
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$254 - $413
Analyst target range
Wall Street analyst consensus shows coverage from 5 analysts, with an average estimated EPS of $16.19 for the coming period. Recent institutional ratings are uniformly positive, with actions from firms like Mizuho, RBC Capital, UBS, and Citigroup all being 'Buy', 'Outperform', or 'Overweight'. A specific consensus target price is not available in the provided data, but the recent rating upgrades and sustained positive outlooks indicate strong analyst confidence in the company's prospects.
Bulls vs Bears: SHW Investment Factors
Sherwin-Williams presents a classic quality vs. valuation dilemma. The company's industry dominance, strong cash generation, and shareholder-friendly policies are offset by high leverage, cyclical pressures on margins, and a stock price in a clear downtrend. The technical weakness contrasts with strong fundamental metrics and analyst support.
Bullish
- Dominant Market Position: Largest U.S. architectural paint provider with premium brand and vast store network.
- Strong Free Cash Flow: Generates $2.65B TTM FCF, supporting dividends and debt service.
- High Return on Equity: ROE of 55.86% indicates highly efficient use of shareholder capital.
- Unanimous Analyst Support: Recent institutional ratings are all positive (Buy/Outperform/Overweight).
Bearish
- High Financial Leverage: Debt-to-equity ratio of 3.16 indicates significant balance sheet risk.
- Profitability Pressure: Q4 net margin of 8.52% down sharply from 13.10% in Q3.
- Technical Downtrend: Price down 11.59% in 1 month, near 52-week low, underperforming SPY.
- Liquidity Concerns: Current ratio of 0.87 suggests potential short-term liquidity constraints.
SHW Technical Analysis
Overall Assessment: The stock has exhibited significant volatility over the past six months, with a clear downtrend from a peak near $373 in mid-February 2026 to a recent close of $320.55. The 6-month price change is -6.79%, underperforming the broader market (SPY -2.82%) over the same period, indicating relative weakness. Short-term Performance: The stock has declined sharply in the near term, with a 1-month change of -11.59% and a 3-month change of -1.07%. This recent weakness contrasts with its 3-month relative strength of +3.56% versus the SPY, suggesting it held up better during the broader market's earlier decline but has since accelerated its sell-off. Current Position: The current price of $320.55 is near the lower end of its 52-week range ($301.58 to $379.65), sitting approximately 19.1% below its 52-week high. This proximity to the yearly low, combined with a recent maximum drawdown of -19.11%, indicates the stock is in a technically oversold zone.
Beta
1.24
1.24x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$302-$380
Price range past year
Annual Return
-10.1%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | -8.8% | -3.6% |
| 3m | -3.0% | -4.0% |
| 6m | -8.3% | -2.0% |
| 1y | -10.1% | +16.2% |
| ytd | -3.0% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue & Profitability: Revenue for Q4 2025 was $5.60 billion, representing a 5.64% year-over-year growth from Q4 2024. However, profitability showed pressure, with Q4 2025 net income of $476.8 million and a net margin of 8.52%, down from the stronger Q3 2025 net income of $833.1 million and a net margin of 13.10%. Financial Health: The company carries a high degree of financial leverage, with a debt-to-equity ratio of 3.16. While this indicates significant debt usage, the company generates substantial cash flow, with trailing twelve-month free cash flow of $2.65 billion, which provides capacity to service its obligations. Operational Efficiency: The company demonstrates strong returns on equity, with a current ROE of 55.86%, indicating efficient use of shareholder capital. However, the current ratio of 0.87 suggests potential short-term liquidity constraints, as current assets do not fully cover current liabilities.
Quarterly Revenue
$5.6B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.48%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Valuation Level: With positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 31.08, while the forward P/E is 23.75, based on the provided estimated EPS of $16.19. The forward P/E suggests a more reasonable valuation relative to near-term earnings expectations. The negative PEG ratio of -11.07 is not meaningful for analysis as it indicates negative or inconsistent growth expectations. Peer Comparison: Industry average valuation metrics are not provided in the data for a direct peer comparison. The company's Price-to-Sales (P/S) ratio of 3.39 and EV/EBITDA of 21.42 can be used for context, but a definitive assessment of relative valuation requires benchmark data.
PE
31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is financial leverage, with a debt-to-equity ratio of 3.16, making the company vulnerable to rising interest rates or an earnings downturn. The current ratio of 0.87 indicates potential liquidity strain, though substantial free cash flow ($2.65B TTM) provides a buffer. Market risks include cyclical exposure to housing and construction markets, evidenced by recent margin compression from 13.10% in Q3 to 8.52% in Q4. The stock's high beta of 1.24 suggests it will be more volatile than the broader market, which is confirmed by its recent 19.11% maximum drawdown and underperformance versus the SPY over the past year (-24.13% relative strength). Operational execution risk is present given the need to maintain premium pricing power in a competitive market.
FAQ
The primary risks are financial and cyclical. The high debt-to-equity ratio of 3.16 creates vulnerability to rising rates or an earnings decline. The current ratio of 0.87 indicates potential short-term liquidity pressure. Cyclically, the company is exposed to housing and industrial markets, with profitability already showing pressure (Q4 net margin 8.52% vs. Q3 13.10%). The stock also has high market beta (1.24), leading to greater volatility, as seen in its 19.11% maximum drawdown.
The 12-month outlook presents a base case target range of $330-$360 (55% probability), assuming EPS meets the $16.19 consensus and the forward P/E holds near 23.75. A bull case to $370-$390 (25% probability) requires a housing recovery and margin expansion. A bear case to $290-$310 (20% probability) could occur with an economic slowdown testing the company's high leverage. The stock is currently technically oversold, trading near its 52-week low of $301.58.
SHW appears fairly valued. The trailing P/E of 31.08 is high, but the forward P/E of 23.75, based on consensus EPS of $16.19, is more reasonable for a market leader. Metrics like EV/EBITDA of 21.42 and P/S of 3.39 are not cheap. The stock is not significantly undervalued, especially considering the balance sheet risk, nor is it egregiously overvalued given its quality and cash flow generation. It trades near the midpoint of its likely fair value range.
Based on a synthesis of the data, SHW is a HOLD at current levels. The company's quality metrics are excellent, including a 55.86% ROE and $2.65B in annual free cash flow. However, the stock faces headwinds from high debt (D/E 3.16), recent margin compression, and a technical downtrend. While analyst sentiment is unanimously positive, the valuation (Forward P/E 23.75) already reflects much of the company's strength, limiting near-term upside potential.
SHW is more suitable for long-term investment. Its Dividend Aristocrat status (47 consecutive increases), durable market position, and strong cash flows align with a long-term, quality-growth strategy. For short-term traders, the lack of clear catalysts, high debt overhang, and technical downtrend present significant challenges. Patient investors can benefit from the company's cyclical recovery potential and reliable capital returns, while weathering near-term volatility.